
Viking Therapeutics and Roche are developing drugs for obesity and diabetes to challenge Eli Lilly and Novo Nordisk’s market duopoly.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Viking Therapeutics and Roche are developing drugs for obesity and diabetes to challenge Eli Lilly and Novo Nordisk’s market duopoly.

Alibaba just unveiled a chip it claims reshapes the AI compute landscape inside China, and the stock is reacting sharply, but one key rival is barely moving, and that gap reveals exactly who the market thinks wins here.

HD's Pro investments are gaining traction in complex purchases, with better delivery tools, broader catalogs and positive Pro comps.

Roche (USOTC:RHHBY) has reported positive results from a mid-stage clinical trial of its experimental obesity treatment enicepatide, with patients who have type 2 diabetes achieving average weight loss of 15. 5% alongside improvements in blood sugar control.
SoFi and Mastercard are exploring additional SoFiUSD use cases, including cross-border payments and remittances.

JPMorgan Chase & Co. seeks to double its GIFT City business over the next couple of years as the Wall Street bank steps up investment in India’s only international financial hub, according to Global Co-Head of Payments Max Neukirchen.
Clear Street raised price target for crypto exchange Bullish, citing that the setback in CLARITY Act could lead to adoption of tokenized stocks.

APOG's $71.8M Groglass acquisition expands its Performance Surfaces capabilities, product offerings and geographic footprint.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its peers.

Alibaba Group (NYSE:BABA), the Chinese technology giant, unveiled a new AI chip and plans to expand its data center capacity at its annual Apsara Conference in Hangzhou on Tuesday. The company introduced the Zhenwu V900, which it called China’s most powerful AI chip and said it delivers three...

United, American lead airline rally, cruise stocks surge as oil prices fall on positive Middle East developments. Airlines, cruises feel for bottom.

Johnson & Johnson (JNJ) stock has returned 58% over the past twelve months, second best in a group of six health care companies. Its revenue growth ranks only fourth of the six. Three peers grew faster and returned less, Eli Lilly among them. The price is a bet that the rest of the business keeps growing once shrinking STELARA sales stop dragging on the total.

Sept 22 (Reuters) - Wall Street's main indexes opened higher on Tuesday, with the tech-heavy Nasdaq hitting an intraday record high for the first time since early June, while investors awaited

Here is how Centene (CNC) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.

Here is how AMC Entertainment (AMC) and Hugo Boss (BOSSY) have performed compared to their sector so far this year.

Here is how BE Semiconductor Industries NV (BESIY) and Dell Technologies (DELL) have performed compared to their sector so far this year.

Nebius just cleared a capacity auction at prices that stunned even its own projections, and the gap between what customers are willing to pay and what the stock currently reflects tells a more complicated story than the tripling share price suggests.

Here is how Ducommun (DCO) and Lockheed Martin (LMT) have performed compared to their sector so far this year.

Here is how Fluor (FLR) and Owens Corning (OC) have performed compared to their sector so far this year.

Disposition was non-discretionary, executed to cover tax withholding from vesting restricted shares. Executive retains direct holdings of 230,542 shares worth $35.4 million.

GS targets a $70B revenue base in 2026 as GBM, AWM and efficiency gains drive growth and strengthen its earnings mix.

The fast-food giant wants the franchisee’s restaurants transferred either to itself or to other franchisees, according to court filings.

The Hennessy Funds portfolio manager argues that market-cap weighting can hide cheaper mid-cap stocks, but investors still need a process for weighing valuation, business improvement, and price confirmation.

RKT hits a 52-week low as high mortgage rates, weak housing demand and rising costs pressure near-term growth despite long-term catalysts.

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) has launched KATE, an AI-powered Training Intelligence platform that turns executives, trainers and subject-matter experts into AI-powered digital trainers while measuring training effectiveness in real time. The company also said it has initiated...

Fed's latest rate hike could support WFC's NII expansion, but rising deposit costs and may limit the upside to some extent.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.